Melatonin and male reproductive health: Relevance of darkness and antioxidant properties

Current Molecular Medicine

Volumn 15, Issue 4, 2015, Pages 299-311

  Rocha, C S ^a   Rato, L ^a   Martins, A D ^a   Alves, M G ^a   Oliveira, P F ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Antioxidant activity; Male reproductive system; Melatonin; Sperm

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALPHA TOCOPHEROL; ANDROGEN; CYCLOPHOSPHAMIDE; DIMPYLATE; GONADOTROPIN; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN 3 RECEPTOR; MELATONIN RECEPTOR; REACTIVE OXYGEN METABOLITE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; ARTICLE; CIRCADIAN RHYTHM; DIABETES MELLITUS; HUMAN; MALE FERTILITY; MALE GENITAL SYSTEM; NIGHT; NONHUMAN; PHYSIOLOGY; REPRODUCTION; SPERM; SPERMATOGENESIS; TESTIS DISEASE; DARKNESS; MALE; METABOLISM; PHOTOPERIODICITY; PINEAL BODY; REPRODUCTIVE HEALTH;

MAMMALIA;

ANTIOXIDANTS; CIRCADIAN RHYTHM; DARKNESS; HUMANS; MALE; MELATONIN; PHOTOPERIOD; PINEAL GLAND; REPRODUCTION; REPRODUCTIVE HEALTH;

EID: 84930982919     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524015666150505155530     Document Type: Article

References (180)

1. [1] Hardeland R, Balzer I, Poeggeler B, et al. On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J Pineal Res 1995; 18(2): 104-11.
2. [2] Lerner AB, Case JD, Heinzelman RV. Structure of Melatonin. J Am Chem Soc 1959; 81(22): 6084-5.
3. [3] Stefulj J, Hortner M, Ghosh M, et al. Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat. J Pineal Res 2001; 30(4): 243-7.
4. [4] Dubbels R, Reiter R, Klenke E, et al. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J Pineal Res 1995; 18(1): 28-31.
5. [5] Tilden AR, Becker MA, Amma LL, Arciniega J, McGaw AK. Melatonin production in an aerobic photosynthetic bacterium: an evolutionarily early association with darkness. J Pineal Res 1997; 22(2): 102-6.
6. [6] Lam RW, Berkowitz AL, Berga SL, Clark CM, Kripke DF, Gillin JC. Melatonin suppression in bipolar and unipolar mood disorders. Psychiatry Res 1990; 33(2): 129-34.
7. [7] Arendt J, Skene DJ, Middleton B, Lockley SW, Deacon S. Efficacy of melatonin treatment in jet lag, shift work, and blindness. J Biol Rhythms 1997; 12(6): 604-17.
8. [8] Perdomo J, Cabrera J, Estevez F, Loro J, Reiter RJ, Quintana J. Melatonin induces apoptosis through a caspasedependent but reactive oxygen species-independent mechanism in human leukemia Molt-3 cells. J Pineal Res 2013; 55(2): 195-206.
9. [9] Raghavendra V, Singh V, Kulkarni SK, Agrewala JN. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 2001; 221(1-2): 57-62.
10. [10] Scalbert E, Guardiola-Lemaitre B, Delagrange P. Melatonin and regulation of the cardiovascular system. Therapie 1998; 53(5): 459-65.
11. [11] Peschke E, Frese T, Chankiewitz E, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006; 40(2): 135-43.
12. [12] Malpaux B, Viguie C, Skinner D, Thiery J, Pelletier J, Chemineau P. Seasonal breeding in sheep: Mechanism of action of melatonin. Anim Reprod Sci 1996; 42(1): 109-17.
13. [13] Shiu SY, Law IC, Lau KW, Tam PC, Yip AW, Ng WT. Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype. J Pineal Res 2003; 35(3): 177-82.
14. [14] van Vuuren RJ, Pitout MJ, van Aswegen CH, Theron JJ. Putative melatonin receptor in human spermatozoa. Clin Biochem 1992; 25(2): 125-7.
15. [15] Armagan A, Uz E, Yilmaz HR, Soyupek S, Oksay T, Ozcelik N. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis. Asian J Androl 2006; 8(5): 595-600.
16. [16] Escames G, Guerrero JM, Reiter RJ, et al. Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci Lett 1997; 230(3): 147-50.
17. [17] Espino J, Bejarano I, Ortiz A, et al. Melatonin as a potential tool against oxidative damage and apoptosis in ejaculated human spermatozoa. Fertil Steril 2010; 94(5): 1915-7.
18. [18] Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51(1): 1-16.
19. [19] Chabra A, Shokrzadeh M, Naghshvar F, Salehi F, Ahmadi A. Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice. Hum Exp Toxicol 2014; 33(2): 185-95.
20. [20] Carlomagno G, Nordio M, Chiu TT, Unfer V. Contribution of myo-inositol and melatonin to human reproduction. Eur J Obstet Gynecol Reprod Biol 2011; 159(2): 267-72.
21. [21] Maronde E, Stehle JH. The mammalian pineal gland: known facts, unknown facets. Trends Endocrinol Metab 2007; 18(4): 142-9.
22. [22] Reiter RJ, Tan D-X, Qi W, Manchester LC, Karbownik M, Calvo JR. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Neurosignals 2000; 9(3-4): 160-71.
23. [23] Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol 2004; 25(3-4): 177-95.
24. [24] Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60(3): 97-108.
25. [25] Ekmekcioglu C, Thalhammer T, Humpeler S, et al. The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 2003; 35(1): 40-4.
26. [26] Konakchieva R, Kyurkchiev S, Kehayov I, Taushanova P, Kanchev L. Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J Neuroimmunol 1995; 63(2): 125-32.
27. [27] Sjoblom M, Jedstedt G, Flemstrom G. Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion. J Clin Invest 2001; 108(4): 625-33.
28. [28] Brydon L, Petit L, Delagrange P, Strosberg AD, Jockers R. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 2001; 142(10): 4264-71.
29. [29] Dillon DC, Easley SE, Asch BB, et al. Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 2002; 118(3): 451-8.
30. [30] Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27(2): 101-10.
31. [31] Nosjean O, Ferro M, Coge F, et al. Identification of the melatonin-binding SiteMT 3 as the quinone reductase 2. J Biol Chem 2000; 275(40): 31311-7.
32. [32] Farce A, Chugunov AO, Loge C, et al. Homology modeling of MT1 and MT2 receptors. Eur J Med Chem 2008; 43(9): 1926.
33. [33] Levoye A, Jockers R, Ayoub MA, Delagrange P, Savaskan E, Guillaume JL. Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors. Chronobiol Int 2006; 23(1-2): 419-26.
34. [34] Pala D, Lodola A, Bedini A, Spadoni G, Rivara S. Homology models of melatonin receptors: challenges and recent advances. Int J Mol Sci 2013; 14(4): 8093-121.
35. [35] Reppert SM. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 1997; 12(6): 528-31.
36. [36] Paul P, Lahaye C, Delagrange P, Nicolas J-P, Canet E, Boutin JA. Characterization of 2-[125I] iodomelatonin binding sites in Syrian hamster peripheral organs. J Pharmacol Exp Ther 1999; 290(1): 334-40.
37. [37] Smirnov A. Nuclear melatonin receptors. Biochemistry (Moscow) 2001; 66(1): 19-26.
38. [38] Wiesenberg I, Missbach M, Carlberg C. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998; 12(2-3): 143-50.
39. [39] Hirose T, Smith RJ, Jetten AM. ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun 1994; 205(3): 1976-83.
40. [40] Benitez-King G, Huerto-Delgadillo L, Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci 1993; 53(3): 201-7.
41. [41] Macias M, Escames G, Leon J, et al. Calreticulin-melatonin. An unexpected relationship. Eur J Biochem 2003; 270(5): 832-40.
42. [42] Cardinali DP, Freire F. Melatonin effects on brain. Interaction with microtubule protein, inhibition of fast axoplasmic flow and induction of crystaloid and tubular formations in the hypothalamus. Mol Cell Endocrinol 1975; 2(5): 317-30.
43. [43] Soto-Vega E, Meza I, Ramirez-Rodriguez G, Benitez-King G. Melatonin stimulates calmodulin phosphorylation by protein kinase C. J Pineal Res 2004; 37(2): 98-106.
44. [44] Sanchez-Barcelo EJ, Cos S, Mediavilla D, Martinez-Campa C, Gonzalez A, Alonso-Gonzalez C. Melatonin-estrogen interactions in breast cancer. J Pineal Res 2005; 38(4): 217-22.
45. [45] Dai J, Inscho EW, Yuan L, Hill SM. Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. J Pineal Res 2002; 32(2): 112-9.
46. [46] Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14(4): 151-68.
47. [47] Costa EJ, Shida CS, Biaggi MH, Ito AS, Lamy-Freund MT. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett 1997; 416(1): 103-6.
48. [48] Ferry G, Ubeaud C, Lambert P, et al. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2, 3-dioxygenase and myeloperoxidase. Biochem J 2005; 388(Pt 1): 205-15.
49. [49] Poeggeler B, Saarela S, Reiter RJ, et al. Melatonin--a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann N Y Acad Sci 1994; 738: 419-20.
50. [50] Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden L, Pablos MI, Tan DX. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53(4): 373-82.
51. [51] Scaiano JC. Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry. J Pineal Res 1995; 19(4): 189-95.
52. [52] Roberts JE, Hu DN, Wishart JF. Pulse radiolysis studies of melatonin and chloromelatonin. J Photochem Photobiol B 1998; 42(2): 125-32.
53. [53] Sofic E, Rimpapa Z, Kundurovic Z, et al. Antioxidant capacity of the neurohormone melatonin. J Neural Transm 2005; 112(3): 349-58.
54. [54] Livrea MA, Tesoriere L, D'Arpa D, Morreale M. Reaction of melatonin with lipoperoxyl radicals in phospholipid bilayers. Free Radic Biol Med 1997; 23(5): 706-11.
55. [55] Kang YS, Kang YG, Park HJ, et al. Melatonin inhibits visfatininduced inducible nitric oxide synthase expression and nitric oxide production in macrophages. J Pineal Res 2013; 55(3): 294-303.
56. [56] Galano A, Tan DX, Reiter RJ. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54(3): 245-57.
57. [57] Maharaj DS, Anoopkumar-Dukie S, Glass BD, et al. The identification of the UV degradants of melatonin and their ability to scavenge free radicals. J Pineal Res 2002; 32(4): 257-61.
58. [58] Oner-Iyidogan Y, Gurdol F, Oner P. The effects of acute melatonin and ethanol treatment on antioxidant enzyme activities in rat testes. Pharmacol Res 2001; 44(2): 89-93.
59. [59] Barlow-Walden LR, Reiter RJ, Abe M, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995; 26(5): 497-502.
60. [60] Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994; 55(24): PL455-60.
61. [61] Lopez-Burillo S, Tan DX, Mayo JC, Sainz RM, Manchester LC, Reiter RJ. Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions. J Pineal Res 2003; 34(4): 269-77.
62. [62] Leon J, Acuna-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38(1): 1-9.
63. [63] Jou MJ, Peng TI, Reiter RJ, Jou SB, Wu HY, Wen ST. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004; 37(1): 55-70.
64. [64] Benitez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 2006; 40(1): 1-9.
65. [65] Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999; 50(2): 271-9.
66. [66] Nordlund JJ, Lerner AB. The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab 1977; 45(4): 768-74.
67. [67] Iriti M, Varoni EM, Vitalini S. Melatonin in traditional Mediterranean diets. J Pineal Res 2010; 49(2): 101-5.
68. [68] Menendez-Pelaez A, Reiter RJ. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 1993; 15(2): 59-69.
69. [69] Kitay JI, Altschule MD. The pineal gland. A review of the physiologic literature. Cambridge: Harvard University Press 1954.
70. [70] Bittman EL, Karsch FJ, Hopkins JW. Role of the pineal gland in ovine photoperiodism: regulation of seasonal breeding and negative feedback effects of estradiol upon luteinizing hormone secretion. Endocrinology 1983; 113(1): 329-36.
71. [71] Reiter RJ, Tan DX, Manchester LC, Paredes SD, Mayo JC, Sainz RM. Melatonin and reproduction revisited. Biol Reprod 2009; 81(3): 445-56.
72. [72] Wu Y-H, Zhou J-N, Balesar R, et al. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotrophin-releasing hormone. J Comp Neurol 2006; 499(6): 897-910.
73. [73] Woo MM, Tai CJ, Kang SK, Nathwani PS, Pang SF, Leung PC. Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab 2001; 86(10): 4789-97.
74. [74] Frungieri MB, Mayerhofer A, Zitta K, Pignataro OP, Calandra RS, Gonzalez-Calvar SI. Direct effect of melatonin on Syrian hamster testes: melatonin subtype 1a receptors, inhibition of androgen production, and interaction with the local corticotropin-releasing hormone system. Endocrinology 2005; 146(3): 1541-52.
75. [75] Gilad E, Pick E, Matzkin H, Zisapel N. Melatonin receptors in benign prostate epithelial cells: Evidence for the involvement of cholera and pertussis toxins–sensitive G proteins in their signal transduction pathways. Prostate 1998; 35(1): 27-34.
76. [76] Cohen HN, Hay ID, Annesley TM, et al. Serum immunoreactive melatonin in boys with delayed puberty. Clin Endocrinol (Oxf) 1982; 17(5): 517-21.
77. [77] Waldhauser F, Weiszenbacher G, Frisch H, Zeitlhuber U, Waldhauser M, Wurtman RJ. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet 1984; 1(8373): 362-5.
78. [78] Silman R, Leone R, Hooper R, Preece M. Melatonin, the pineal gland and human puberty. Nature 1979; 282(5736): 301-3.
79. [79] Kumanov P, Tomova A, Isidori A, Nordio M. Altered melatonin secretion in hypogonadal men: clinical evidence. Int J Androl 2005; 28(4): 234-40.
80. [80] Kadva A, Djahanbakhch O, Monson J, Di WL, Silman R. Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 1998; 83(10): 3653-62.
81. [81] Ng TB, Lo LL. Inhibitory actions of pineal indoles on steroidogenesis in isolated rat Leydig cells. J Pineal Res 1988; 5(3): 229-43.
82. [82] Valenti S, Giusti M, Guido R, Giordano G. Melatonin receptors are present in adult rat Leydig cells and are coupled through a pertussis toxin-sensitive G-protein. Eur J Endocrinol 1997; 136(6): 633-9.
83. [83] Izzo G, Francesco A, Ferrara D, et al. Expression of melatonin (MT1, MT2) and melatonin-related receptors in the adult rat testes and during development. Zygote 2010; 18(03): 257-64.
84. [84] Olivares A, Valladares L, Bustos-Obregon E, Nunez S. Testicular function of sexually immature rats chronically treated with melatonin. Arch Biol Med Exp 1989; 22(4): 387.
85. [85] Valenti S, Guido R, Giusti M, Giordano G. In vitro acute and prolonged effects of melatonin on purified rat Leydig cell steroidogenesis and adenosine 3', 5'-monophosphate production. Endocrinology 1995; 136(12): 5357-62.
86. [86] Hagen SC, Asher JH, Jr. Effects of pinealectomy on reproduction in the Syrian hamster mutant anophthalmic white (Wh). Am J Anat 1983; 167(4): 523-38.
87. [87] Erlich SS, Apuzzo ML. The pineal gland: anatomy, physiology, and clinical significance. J Neurosurg 1985; 63(3): 321-41.
88. [88] Prendergast BJ, Hugenberger JL. Frequency coding of melatonin signals sufficient to induce testicular growth in photoregressed Siberian hamsters. J Neuroendocrinol 1999; 11(4): 237-41.
89. [89] Elliott JA, Bartness TJ, Goldman BD. Effect of melatonin infusion duration and frequency on gonad, lipid, and body mass in pinealectomized male Siberian hamsters. J Biol Rhythms 1989; 4(4): 439-55.
90. [90] Ooi VE, Ng TB. Histological studies on the effects of pineal 5-methoxyindoles on the reproductive organs of the male golden hamster. J Pineal Res 1989; 7(4): 315-24.
91. [91] Reiter RJ, Rudeen PK, Sackman JW, Vaughan MK, Johnson LY, Little JC. Subcutaneous melatonin implants inhibit reproductive atrophy in male hamsters induced by daily melatonin injections. Endocr Res Commun 1977; 4(1): 35-44.
92. [92] Niedziela M, Lerchl A, Nieschlag E. Direct effects of the pineal hormone melatonin on testosterone synthesis of Leydig cells in Djungarian hamsters (Phodopus sungorus) in vitro. Neurosci Lett 1995; 201(3): 247-50.
93. [93] Rossi SP, Matzkin ME, Terradas C, et al. New insights into melatonin/CRH signaling in hamster Leydig cells. Gen Comp Endocrinol 2012; 178(1): 153-63.
94. [94] Frungieri MB, Mayerhofer A, Zitta K, Pignataro OP, Calandra RS, Gonzalez-Calvar SI. Direct effect of melatonin on Syrian hamster testes: melatonin subtype 1a receptors, inhibition of androgen production, and interaction with the local corticotropin-releasing hormone system. Endocrinology 2005; 146(3): 1541-52.
95. [95] Awad H, Halawa F, Mostafa T, Atta H. Melatonin hormone profile in infertile males. Int J Androl 2006; 29(3): 409-13.
96. [96] Kocher L, Lornage J, Claustrat B. Persistence of fertility despite semen alterations in a pinealectomised patient treated with melatonin. Neuro Endocrinol Lett 2013; 34(8): 763-6.
97. [97] Luboshitzky R, Shen-Orr Z, Herer P. Seminal plasma melatonin and gonadal steroids concentrations in normal men. Arch Androl 2002; 48(3): 225-32.
98. [98] Shiu SY, Li L, Siu SW, Xi SC, Fong SW, Pang SF. Biological basis and possible physiological implications of melatonin receptor-mediated signaling in the rat epididymis. Biol Signals Recept 2000; 9(3-4): 172-87.
99. [99] Siu SW, Lau KW, Tam PC, Shiu SY. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 2002; 52(2): 106-22.
100. [100] Levine RJ, Mathew RM, Chenault CB, et al. Differences in the quality of semen in outdoor workers during summer and winter. N Engl J Med 1990; 323(1): 12-6.
101. [101] Irez TO, Senol H, Alagoz M, et al. Effects of indoleamines on sperm motility in vitro. Hum Reprod 1992; 7(7): 987-90.
102. [102] Lerchl A. Melatonin administration alters semen quality in normal men. J Androl 2004; 25(2): 185-6; author reply 6-7.
103. [103] Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980; 210(4475): 1267-9.
104. [104] Tijmes M, Pedraza R, Valladares L. Melatonin in the rat testis: evidence for local synthesis. Steroids 1996; 61(2): 65-8.
105. [105] Bornman M, Oosthuizen J, Barnard H, Schulenburg G, Boomker D, Reif S. Melatonin and sperm motility/melatonin und spermatozoenmotilitat. Andrologia 1989; 21(5): 483-5.
106. [106] Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47(2): 109-26.
107. [107] Hardeland R. Melatonin and its metabolites as antinitrosating and anti-nitrating agents. J Exp Integr Med 2011; 1(2): 67-81.
108. [108] Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47(10): 2336-48.
109. [109] Okumura A, Fuse H, Kawauchi Y, Mizuno I, Akashi T. Changes in male reproductive function after high altitude mountaineering. High Alt Med Biol 2003; 4(3): 349-53.
110. [110] Shevantaeva ON, Kosyuga YI. Effect of acute hypobaric hypoxia on spermatogenesis and lactate concentration in testicular tissue of male albino rats. Bull Exp Biol Med 2006; 141(1): 20-2.
111. [111] Farias JG, Bustos-Obregon E, Reyes JG. Increase in testicular temperature and vascularization induced by hypobaric hypoxia in rats. J Androl 2005; 26(6): 693-7.
112. [112] Vargas A, Bustos-Obregon E, Hartley R. Effects of hypoxia on epididymal sperm parameters and protective role of ibuprofen and melatonin. Biol Res 2011; 44(2): 161-7.
113. [113] Hartley R, Castro-Sanchez R, Ramos-Gonzalez B, Bustos-Obregon E. Rat spermatogenesis damage in intermittent hypobaric hypoxia and the protective role of melatonin. I Cauda epididymal spermatozoa. Int J Morphology 2009; 27(4): 1275-84.
114. [114] Bustos-Obregon E, Castro-Sanchez R, Ramos B, Torres-Diaz L. Rat spermatogenesis damage in intermittent hypobaric hypoxia and the protective role of melatonin. II: testicular parameters. Int J Morphology 2010; 28(2): 537-47.
115. [115] Anderson JB, Williamson RC. The fate of the human testes following unilateral torsion of the spermatic cord. Br J Urol 1986; 58(6): 698-704.
116. [116] Williamson RC. Torsion of the testis and allied conditions. Br J Surg 1976; 63(6): 465-76.
117. [117] Filho D, Torres MA, Bordin AL, Crezcynski-Pasa TB, Boveris A. Spermatic cord torsion, reactive oxygen and nitrogen species and ischemia–reperfusion injury. Mol Asp Med 2004; 25(1): 199-210.
118. [118] Kanter M. Protective effects of melatonin on testicular torsion/detorsion-induced ischemia-reperfusion injury in rats. Exp Mol Pathol 2010; 89(3): 314-20.
119. [119] Koksal M, Oguz E, Baba F, et al. Effects of melatonin on testis histology, oxidative stress and spermatogenesis after experimental testis ischemia-reperfusion in rats. Eur Rev Med Pharmacol Sci 2012; 16(5): 582-8.
120. [120] Kurcer Z, Hekimoglu A, Aral F, Baba F, Sahna E. Effect of melatonin on epididymal sperm quality after testicular ischemia/reperfusion in rats. Fertil Steril 2010; 93(5): 1545-9.
121. [121] Ekici S, Dogan Ekici AI, Ozturk G, et al. Comparison of melatonin and ozone in the prevention of reperfusion injury following unilateral testicular torsion in rats. Urology 2012; 80(4): 899-906.
122. [122] Yurtcu M, Abasiyanik A, Avunduk MC, Muhtaroglu S. Effects of melatonin on spermatogenesis and testicular ischemiareperfusion injury after unilateral testicular torsion-detorsion. J Pediatr Surg 2008; 43(10): 1873-8.
123. [123] Piomboni P, Focarelli R, Stendardi A, Ferramosca A, Zara V. The role of mitochondria in energy production for human sperm motility. Int J Androl 2012; 35(2): 109-24.
124. [124] Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003; 79(4): 829-43.
125. [125] Aitken RJ, Ryan AL, Baker MA, McLaughlin EA. Redox activity associated with the maturation and capacitation of mammalian spermatozoa. Free Radic Biol Med 2004; 36(8): 994-1010.
126. [126] Allamaneni SS, Naughton CK, Sharma RK, Thomas AJ, Jr, Agarwal A. Increased seminal reactive oxygen species levels in patients with varicoceles correlate with varicocele grade but not with testis size. Fertil Steril 2004; 82(6): 1684-6.
127. [127] de Lamirande E, Tsai C, Harakat A, Gagnon C. Involvement of reactive oxygen species in human sperm arcosome reaction induced by A23187, lysophosphatidylcholine, and biological fluid ultrafiltrates. J Androl 1998; 19(5): 585-94.
128. [128] Bornman MS, Oosthuizen JM, Barnard HC, Schulenburg GW, Boomker D, Reif S. Melatonin and sperm motility. Andrologia 1989; 21(5): 483-5.
129. [129] Fujinoki M. Melatonin-enhanced hyperactivation of hamster sperm. Reproduction 2008; 136(5): 533-41.
130. [130] Gwayi N, Bernard RT. The effects of melatonin on sperm motility in vitro in Wistar rats. Andrologia 2002; 34(6): 391-6.
131. [131] Du Plessis S, Hagenaar K, Lampiao F. The in vitro effects of melatonin on human sperm function and its scavenging activities on NO and ROS. Andrologia 2010; 42(2): 112-6.
132. [132] Espino J, Ortiz A, Bejarano I, et al. Melatonin protects human spermatozoa from apoptosis via melatonin receptor-and extracellular signal-regulated kinase-mediated pathways. Fertil Steril 2011; 95(7): 2290-6.
133. [133] Ortiz A, Espino J, Bejarano I, et al. High endogenous melatonin concentrations enhance sperm quality and short-term in vitro exposure to melatonin improves aspects of sperm motility. J Pineal Res 2011; 50(2): 132-9.
134. [134] Huang F, Ning H, Xin QQ, et al. Melatonin pretreatment attenuates 2-bromopropane-induced testicular toxicity in rats. Toxicology 2009; 256(1-2): 75-82.
135. [135] Espino J, Ortiz A, Bejarano I, et al. Melatonin protects human spermatozoa from apoptosis via melatonin receptor-and extracellular signal-regulated kinase-mediated pathways. Fertil Steril 2011; 95(7): 2290-6.
136. [136] Konakchieva R, Todorov P. Melatonin protects human spermatozoa from apoptosis via melatonin receptor-and extracellular signal-regulated kinase-mediated pathways. Fertil Steril 2011; 96(4): e159.
137. [137] Radogna F, Cristofanon S, Paternoster L, et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008; 44(3): 316-25.
138. [138] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 (Suppl 1): S64-71.
139. [139] Bonnefond A, Clement N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 2012; 44(3): 297-301.
140. [140] Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 41(1): 82-8.
141. [141] Tutuncu NB, Batur MK, Yildirir A, et al. Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy. J Pineal Res 2005; 39(1): 43-9.
142. [142] McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP. Melatonin secretion and the incidence of type 2 diabetes. JAMA 2013; 309(13): 1388-96.
143. [143] Paskaloglu K, Sener G, Ayangolu-Dulger G. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur J Pharmacol 2004; 499(3): 345-54.
144. [144] Gorgun FM, Ozturk Z, Gumustas MK, Kokogu E. Melatonin administration affects plasma total sialic acid and lipid peroxidation levels in streptozotocin induced diabetic rats. J Toxicol Environ Health A 2002; 65(10): 695-700.
145. [145] Baydas G, Canatan H, Turkoglu A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 2002; 32(4): 225-30.
146. [146] Alves MG, Oliveira PF. Diabetes Mellitus and male reproductive function: where we stand? Int J Diab Vasc Res 2013; 1(1): 1-3.
147. [147] Agbaje I, Rogers D, McVicar C, et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod 2007; 22(7): 1871-7.
148. [148] Faerman I, Glocer L, Fox D, Jadzinsky MN, Rapaport M. Impotence and diabetes: histological studies of the autonomic nervous fibers of the corpora cavernosa in impotent diabetic males. Diabetes 1974; 23(12): 971-6.
149. [149] Cameron DF, Murray FT, Drylie DD. Interstitial compartment pathology and spermatogenic disruption in testes from impotent diabetic men. Anat Rec 1985; 213(1): 53-62.
150. [150] Seethalakshmi L, Menon M, Diamond D. The effect of streptozotocin-induced diabetes on the neuroendocrine-male reproductive tract axis of the adult rat. J Urol 1987; 138(1): 190.
151. [151] Alves MG, Martins AD, Rato L, Moreira PI, Socorro S, Oliveira PF. Molecular mechanisms beyond glucose transport in diabetes-related male infertility. Biochim Biophys Acta 2013; 1832(5): 626-35.
152. [152] Rato L, Alves M, Dias T, et al. High-energy diets may induce a pre-diabetic state altering testicular glycolytic metabolic profile and male reproductive parameters. Andrology 2013; 1(3): 495-504.
153. [153] Rato L, Duarte AI, Tomas GD, et al. Pre-diabetes alters testicular PGC1-α/SIRT3 axis modulating mitochondrial bioenergetics and oxidative stress. Biochim Biophys Acta 2013; 1837(3): 335-44.
154. [154] Guneli E, Tugyan K, Ozturk H, Gumustekin M, Cilaker S, Uysal N. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats. Eur Surg Res 2008; 40(4): 354-60.
155. [155] Zhang K, Lv Z, Jia X, Huang D. Melatonin prevents testicular damage in hyperlipidaemic mice. Andrologia 2012; 44(4): 230-6.
156. [156] Game C, Gagnon MM, Webb D, Lim R. Endocrine disruption in male mosquitofish (Gambusia holbrooki) inhabiting wetlands in Western Australia. Ecotoxicology 2006; 15(8): 665-72.
157. [157] Pant N, Upadhyay G, Pandey S, Mathur N, Saxena DK, Srivastava SP. Lead and cadmium concentration in the seminal plasma of men in the general population: correlation with sperm quality. Reprod Toxicol 2003; 17(4): 447-50.
158. [158] Kaur F, Sangha GK, Bilaspuri GS. Cyclophosphamideinduced structural and biochemical changes in testis and epididymidis of rats. Indian J Exp Biol 1997; 35(7): 771-5.
159. [159] Reiter RJ, Carneiro RC, Oh CS. Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res 1997; 29(8): 363-72.
160. [160] Anjum S, Rahman S, Kaur M, et al. Melatonin ameliorates bisphenol A-induced biochemical toxicity in testicular mitochondria of mouse. Food Chem Toxicol 2011; 49(11): 2849-54.
161. [161] Ji YL, Wang H, Zhao XF, et al. Crosstalk between endoplasmic reticulum stress and mitochondrial pathway mediates cadmium-induced germ cell apoptosis in testes. Toxicol Sci 2011; 124(2): 446-59.
162. [162] Ji YL, Wang H, Meng C, et al. Melatonin alleviates cadmiuminduced cellular stress and germ cell apoptosis in testes. J Pineal Res 2012; 52(1): 71-9.
163. [163] Pina-Guzman B, Solis-Heredia MJ, Quintanilla-Vega B. Diazinon alters sperm chromatin structure in mice by phosphorylating nuclear protamines. Toxicol Appl Pharmacol 2005; 202(2): 189-98.
164. [164] Salazar-Arredondo E, de Jesus Solis-Heredia M, Rojas-Garcia E, Hernandez-Ochoa I, Quintanilla-Vega B. Sperm chromatin alteration and DNA damage by methyl-parathion, chlorpyrifos and diazinon and their oxon metabolites in human spermatozoa. Reprod Toxicol 2008; 25(4): 455-60.
165. [165] Bustos-Obregon E, Gonzalez JR, Espinoza O. Melatonin as protective agent for the cytotoxic effects of diazinon in the spermatogenesis in the earthworm Eisenia foetida. Ital J Anat Embryol 2005; 110(2 Suppl 1): 159-65.
166. [166] Sarabia L, Maurer I, Bustos-Obregon E. Melatonin prevents damage elicited by the organophosphorous pesticide diazinon on mouse sperm DNA. Ecotoxicol Environ Saf 2009; 72(2): 663-8.
167. [167] Kim Y, Jung K, Hwang T, et al. Hematopoietic and reproductive hazards of Korean electronic workers exposed to solvents containing 2-bromopropane. Scand J Work Environ Health 1996; 22(5): 387-91.
168. [168] Yu X, Kubota H, Wang R, et al. Involvement of Bcl-2 family genes and Fas signaling system in primary and secondary male germ cell apoptosis induced by 2-bromopropane in rat. Toxicol Appl Pharmacol 2001; 174(1): 35-48.
169. [169] Boekelheide K, Darney SP, Daston GP, et al. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of 2-bromopropane. Reprod Toxicol 2004; 18(2): 189-217.
170. [170] Jiang FX. Behaviour of spermatogonia following recovery from busulfan treatment in the rat. Anat Embryol (Berl) 1998; 198(1): 53-61.
171. [171] Ghasemi FM, Faghani M, Khajehjahromi S, Bahadori M, Nasiri EE, Hemadi M. Effect of Melatonin on proliferative activity and apoptosis in spermatogenic cells in mouse under chemotherapy. J Reprod Contracept 2010; 21(2): 79-94.
172. [172] Robaire B, Hales BF. Mechanisms of action of cyclophosphamide as a male-mediated developmental toxicant. Adv Exp Med Biol 2003; 518: 169-80.
173. [173] Meistrich ML, Parchuri N, Wilson G, Kurdoglu B, Kangasniemi M. Hormonal protection from cyclophosphamideinduced inactivation of rat stem spermatogonia. J Androl 1995; 16(4): 334-41.
174. [174] Ghosh D, Das UB, Ghosh S, Mallick M, Debnath J. Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress. Drug Chem Toxicol 2002; 25(3): 281-92.
175. [175] Haque R, Bin-Hafeez B, Ahmad I, Parvez S, Pandey S, Raisuddin S. Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum Exp Toxicol 2001; 20(12): 643-50.
176. [176] La Fleur SE, Kalsbeek A, Wortel J, van der Vliet J, Buijs RM. Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. J Neuroendocrinol 2001; 13(12): 1025-32.
177. [177] Rato L, Alves MG, Socorro S, Duarte AI, Cavaco JE, Oliveira PF. Metabolic regulation is important for spermatogenesis. Nat Rev Urol 2012; 9(6): 330-8.
178. [178] Alves MG, Rato L, Carvalho RA, Moreira PI, Socorro S, Oliveira PF. Hormonal control of Sertoli cell metabolism regulates spermatogenesis. Cell Mol Life Sci 2013; 70(5): 777-93.
179. [179] Persengiev S, Kehajova J. Inhibitory action of melatonin and structurally related compounds on testosterone production by mouse Leydig cells in vitro. Cell Biochem Funct 1991; 9(4): 281-6.
180. [180] Watson RR. Melatonin in the Promotion of Health. USA: CRC Press 2012.